Larvol Delta - CASI-Cleave-Therapeutics-Licenses-FirstinClass-VCPP97-Inhibitor-CB5339-To-CASI-Pharmaceuticals-For-Greater-China-Region-httpstcoBBtXCNexhM

CB-5339 - Cleave Therap

VCP/p97 inhibitors - Cleave Therap

https://twitter.com/stock_titan/status/1368909475772575746

Mar 8, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next